Master Data

Registry
Register court Mannheim HRB 733472
Registered
5/22/2019
Industry
Activities of holding companiesResearch and experimental development on biotechnologyDiagnostic imaging activities
Purpose
Gegenstand geändert; nun: Die präklinische und klinische Entwicklung sowie die Kommerzialisierung von organspezifischen Adeno-assoziierten viralen (AAV) Vektoren sowie organ-spezifischen AAV-basierten Gentherapien zur Behandlung erworbener und genetischbedingter kardiovaskulärer und kardiopulmonaler Erkrankungen sowie, nachrangig, weiterer verwandter medizinischer Indikationsfelder, insbesondere die Verwendung organspezifischer AAV Kapside für Gentherapien neurologischer, neuromuskulärer oder metabolischer Erkrankungen, auch ohne Beteiligung des Herzens.

History

No events found for this filter

Management

NameRole
Martin Dr. Busch
since 1/8/2026
Procura
Managing Director
Patrick Prof. Dr. Most
since 5/22/2019
Managing Director

Beneficial Owners
Beta

Identified persons (4)

Unresolved chains (1)

Shareholders
Beta

5 shareholders

GmbH structure

4 of 5 shown

Name
Location
Amount
Share
DH-LT-Investments GmbH
Germany
€16,238
41.12%
M***** B****
€5,814
14.72%
H*** A***** K****
€5,814
14.72%
M*** J******* L************
€5,814
14.72%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)

Organizations at this Address

39 nearby organizations

List of companies and organizations located at or near this business address. Data includes company names, addresses, registration details, and industry classifications.
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.